|
Meeting SummaryThe retinoblastoma tumor suppressor (RB1) was discovered due to its role in the childhood eye cancer, retinoblastoma, but is part of a pathway that is defective in most, if not all human cancers. Moreover, it is conserved in diverse organisms including mammals, plants, worms, and flies. The initial biological function ascribed to RB protein was cell cycle regulation, and the connection between RB, its relatives p107 (RBL1) and p130 (RBL2), and the E2f family of transcription factors is now text book material. But insight into other target proteins and RB functions has expanded furiously. RB has been linked with diverse processes including apoptosis, autophagy, senescence, genome stability, immunity, telomere function, stem cell biology, and the development of many cell types, including placental trophoblasts, neurons, muscle, epithelia, erythrocytes and many others. In view of its broad importance to human biology and human health, we felt it would be exciting to hold an international RB meeting to bring together leading and emerging experts in the field. The first meeting was held in 2009 and there was considerable enthusiasm for a biennial event. The speakers list at that meeting can be seen here. A summary of the exciting topics at the first meeting was published in Cancer Research. In addition to regular seminars from invited speakers we also have arranged:
We hope you will join us at the 2nd International RB Meeting. We look forward to seeing you in Toronto for Nov 17th and 18th, 2011. Meeting Organizers 2011: Rod Bremner and Eldad Zacksenhaus Steering Committee 2011: Rod Bremner, Eldad Zacksenhaus, Fred Dick, Erik Knudsen and Julien Sage
|







